Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/23/2012US8293783 Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (COPD)
10/23/2012US8293782 Compound, probe containing the novel compound, and fluorescence-imaging contrast agent containing the novel compound or the probe
10/23/2012US8293781 Indole derivatives having cPLA2 inhibiting activity and applications and production methods of the same
10/23/2012US8293780 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making
10/23/2012US8293779 Mazindol combination in the treatment of attention deficit/hyperactivity
10/23/2012US8293778 Heterocyclic antiviral compounds
10/23/2012US8293777 Angiotensin II receptor antagonists
10/23/2012US8293776 Compositions and methods for treating inflammatory conditions of the bowel
10/23/2012US8293775 Benzoxazolone derivatives, processes for preparing them and their uses
10/23/2012US8293774 Optically active (R)-aryloxypropionic acid amides and herbicidal composition comprising same
10/23/2012US8293773 1, 2, 3-triazole derivatives as new cannabinoid-1 receptor antagonists
10/23/2012US8293772 Triazole substituted aminobenzophenone compounds
10/23/2012US8293771 p38 MAP kinase inhibitors
10/23/2012US8293770 Pyrrolidine derivatives as NK-3 receptor antagonists
10/23/2012US8293769 CSF-1R inhibitors, compositions, and methods of use
10/23/2012US8293768 Organic compounds
10/23/2012US8293767 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
10/23/2012US8293765 Injectable depot formulation comprising crystals of iloperidone
10/23/2012US8293764 Compositions and methods for disruption of BRCA2-Rad51 interaction
10/23/2012US8293763 8-anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents
10/23/2012US8293762 Isoquinolinopyrrolopyridinones active as kinase inhibitors
10/23/2012US8293761 Certain chemical entities, compositions and methods
10/23/2012US8293760 Cyclopamine lactam analogs and methods of use thereof
10/23/2012US8293759 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
10/23/2012US8293758 Substituted spirocyclic cyclohexane derivatives
10/23/2012US8293757 5-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
10/23/2012US8293756 Pharmaceutical compositions comprising nilotinib hydrochloride monohydrate
10/23/2012US8293755 Treatment of statin side effects using uridine derivatives
10/23/2012US8293754 Thienopyrimidine derivatives
10/23/2012US8293753 Substituted 2-carboxamide cycloamino ureas
10/23/2012US8293752 Compounds useful as Raf kinase inhibitors
10/23/2012US8293751 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/23/2012US8293750 Pyrazines as delta opioid receptor modulators
10/23/2012US8293749 Injectable meclizine formulations and methods
10/23/2012US8293748 p38 MAP kinase inhibitors
10/23/2012US8293747 Heterocyclic amide compounds as protein kinase inhibitors
10/23/2012US8293746 Pyrimidinyl aryl urea derivatives being FGF inhibitors
10/23/2012US8293745 Use of imatinib to treat liver disorders and viral infections
10/23/2012US8293744 Heterocyclic fused cinnoline M1 receptor positive allosteric modulators
10/23/2012US8293743 Substituted imidazo[1,2-A]pyrazine derivatives as alpha-helix mimetics and method relating to the treatment of cancer stem cells
10/23/2012US8293742 Preferential vasoconstriction compositions and methods of use
10/23/2012US8293741 Associated with diabetes; implanting an alpha-2 adrenergic receptor agonist, such as brimonidine tartrate, associated with a biodegradable polymer matrix; hypotensive agents, antiischemic agents; vision defects
10/23/2012US8293740 Sigma receptor inhibitors
10/23/2012US8293739 Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof
10/23/2012US8293738 Indazole inhibitors of kinase
10/23/2012US8293737 Anxiolytic compounds
10/23/2012US8293736 Purine compounds selective for PI3K P110 delta, and methods of use
10/23/2012US8293735 Thienopyrimidine derivatives as P13K inhibitors
10/23/2012US8293734 Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
10/23/2012US8293733 Oil dispersions of nAChR binding neonicotinoids
10/23/2012US8293732 Antibacterial quinoline derivatives
10/23/2012US8293731 HIV integrase inhibitors
10/23/2012US8293730 Substituted imidazo[1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives
10/23/2012US8293729 Compounds, pharmaceutical composition and methods relating thereto
10/23/2012US8293728 Methods of treating hypertriglyceridemia
10/23/2012US8293727 Methods of treating hypertriglyceridemia
10/23/2012US8293726 Treatment of cancer and other diseases
10/23/2012US8293725 Peptidomimetic inhibitors of PSMA, compounds comprising them, and methods of use
10/23/2012US8293724 Therapeutic applications of fatty acid amide hydrolase inhibitors
10/23/2012US8293723 Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications
10/23/2012US8293722 Inhibition of cathepsin K activity and the treatment and prevention of disease
10/23/2012US8293721 CETP inhibitors derived from benzoxazole arylamides
10/23/2012US8293720 Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
10/23/2012US8293719 iRNA agents targeting VEGF
10/23/2012US8293715 10a-Azalide compound crosslinked at 10a- and 12-positions
10/23/2012US8293712 Cosmetic composition for stimulating the synthesis of proteins of the basement membrane
10/23/2012US8293700 Anti-bacterial composition especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
10/23/2012US8293513 Histone deacetylase inhibitors
10/23/2012US8293479 Use of parathyroid hormone-related protein(PTHRP) in the diagnosis and treatment of chronic lung disease and other pathologies
10/23/2012US8293464 Methods for reducing the internalization of viruses and identification of compounds effective thereof
10/23/2012US8293290 Annatto extract compositions, including geranyl geraniols and methods of use
10/23/2012US8293278 Compositions and methods for inhibiting reproduction in tadpole shrimp
10/23/2012US8293276 Drug loaded polymeric nanoparticles and methods of making and using same
10/23/2012US8293275 Spray freeze dry of compositions for pulmonary administration
10/23/2012US8293273 Controlled release and taste masking oral pharmaceutical composition
10/23/2012US8293269 Compositions for promoting sleep
10/23/2012US8293268 Local administration of gallium compositions to treat pain
10/23/2012US8293267 Method for preparing an antimicrobial cotton of cellulose matrix having chemically and/or physically bonded silver and antimicrobial cotton prepared therefrom
10/23/2012US8293266 Paromomycin-supplemented feed stuff for turkey and use thereof for prophylaxis of histomoniasis, reduction of the horizontal spreading of histomoniasis, and for improved weight gain and feed conversion
10/23/2012US8293240 Method of treating drug-resistant cancer
10/23/2012US8293232 Flowable carrier matrix and methods for delivering to a patient
10/23/2012US8293222 Silicone-modified wax-containing composition and cosmetic preparation containing the composition
10/23/2012US8293218 Skin care compositions comprising substituted monoamines
10/23/2012US8293211 CB1 receptor antagonists and uses thereof
10/23/2012US8293210 Extruding mixture of alpha-2 adrenergic receptor agonist (brimonidine) and biodegradable polylactide
10/23/2012CA2736751C Salts of n-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
10/23/2012CA2706634C Preparation of powder agglomerates
10/23/2012CA2706180C Novel glucocorticoid receptor agonists
10/23/2012CA2699599C Pharmacological adjunctive treatment associated with glaucoma filtration surgery
10/23/2012CA2693457C Inhibitors of 11b-hydroxysteroid dehydrogenase
10/23/2012CA2689659C Nitrogen-containing heterocyclic derivative having 11.beta.-hydroxysteroid dehydrogenase type 1 inhibitory activity
10/23/2012CA2679626C Fluoroquinolones for treating, reducing, ameliorating, or preventing infections caused by antibacterial-drug resistant bacteria
10/23/2012CA2672903C Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer
10/23/2012CA2654661C Compositions comprising modified lcat and use thereof for treating atherosclerosis
10/23/2012CA2650036C Compositions and kits useful for treatment of respiratory illness
10/23/2012CA2601096C Treatment of inflammatory bowel disease
10/23/2012CA2584457C Antisense oligonucleotides for treating allergy and neoplastic cell proliferation
10/23/2012CA2570148C Stabilized compositions comprising a therapeutically active agent, citric acid or a conjugated base and chlorine dioxide
10/23/2012CA2569464C 5-thio-piperdinyl prostaglandin e analogs
10/23/2012CA2566526C Naphthaline derivatives useful as histamine-3-receptor ligands
1 ... 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 ... 7860